INTERACTION BETWEEN TYPE 2 DIABETES MELLITUS, OBESITY RELATED METABOLIC DISORDERS AND NON PHARMACOLOGICAL THERAPIES
PDF (Português (Brasil))

Keywords

Diabetes Mellitus Tipo 2
Obesidade
Intervenção dietética
Exercícios Físicos
Controle do Estresse
Perda de peso

How to Cite

Barcelos Carvalho, B. A., Trettel de Oliveira, M. C., Vilela Camilo, L., Guareschi, J. V., Machado Oliveira, B. R., Mossini Gratão, V., Trindade dos Santos, L. F., Oliveira Rassi, P. L., Neves de Souza, B., Dalton Doering, J., & Carvalhaes Filho, C. A. (2024). INTERACTION BETWEEN TYPE 2 DIABETES MELLITUS, OBESITY RELATED METABOLIC DISORDERS AND NON PHARMACOLOGICAL THERAPIES . Brazilian Journal of Implantology and Health Sciences, 6(12), 2107–2125. https://doi.org/10.36557/2674-8169.2024v6n12p2107-2125

Abstract

Type 2 Diabetes Mellitus (T2DM) and obesity are interrelated conditions that have a significant impact on global metabolic health. Obesity contributes to insulin resistance, the central mechanism of T2DM, while T2DM can lead to weight gain. These conditions require integrated interventions involving pharmacological therapies and lifestyle changes such as diet, exercise, and stress management. A systematic literature review was conducted, encompassing 4,325 publications from PubMed, Scopus, Google Scholar, and Cochrane Library, using keywords related to T2DM, obesity, and non-pharmacological therapies. After a thorough analysis, 28 studies were selected, including randomized clinical trials and systematic reviews. The data analyzed focused on the effects of dietary, physical, and behavioral interventions on glycemic control, weight loss, and metabolic parameters. Non-pharmacological interventions demonstrated substantial benefits in glycemic control, with significant reductions in glycated hemoglobin (HbA1c) levels and decreased reliance on hypoglycemic medications. Regular physical exercise, particularly combining aerobic and resistance activities, promoted visceral fat reduction and improved insulin sensitivity. Dietary changes, such as consuming low-glycemic index foods, also showed positive effects. Stress management was crucial in modulating psychosocial factors, enhancing treatment adherence. Barriers such as limited access to healthy resources and obesity-related stigma highlighted the importance of public policies and personalized strategies. The integration of non-pharmacological therapies into T2DM and obesity management provides an effective approach, improving metabolic control, reducing complications, and promoting quality of life. However, socioeconomic challenges and the need for constant follow-up reinforce the importance of inclusive public policies and personalized multidisciplinary approaches. Combining pharmacological and non-pharmacological strategies is essential for more effective and sustainable care.

https://doi.org/10.36557/2674-8169.2024v6n12p2107-2125
PDF (Português (Brasil))

References

American Diabetes Association. (2023). Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Supplement 1), S1–S2. https://doi.org/10.2337/dc23-Sint1

Barreto, S. M., & Almeida, L. M. (2021). Terapias não farmacológicas no tratamento do Diabetes Mellitus Tipo 2: Estratégias e evidências. Revista Brasileira de Diabetes, 22(3), 27-34.

Bluher, M. (2019). Obesity: Epidemiology and clinical management. Springer.

Bray, G. A., & Frühbeck, G. (2018). The role of lifestyle in the management of obesity. Obesity Reviews, 19(10), 1120-1129.

Cai, W., Wu, S., & Xu, M. (2022). Obesity and insulin resistance in type 2 diabetes: Mechanisms and therapeutics. Frontiers in Endocrinology, 13, 904357.

Garber, A. J., & Handelsman, Y. (2021). Diabetes management and therapeutic approaches: Current and future options. Endocrine Practice, 27(6), 574-582.

Gordon, M. T., & Henderson, J. (2018). Exercise and its role in the management of type 2 diabetes and obesity. Journal of Clinical Endocrinology, 103(5), 2156-2165.

Gülmez, O., Gülmez, H., & Demirtaş, S. (2019). Impact of lifestyle changes in the management of diabetes and obesity. Journal of Diabetes Research, 2019, 1-8.

Jansson, L., & Nilsson, G. (2023). Diet and exercise interventions in the management of diabetes mellitus and obesity. Journal of Obesity and Metabolic Syndrome, 32(2), 103-109.

Kahn, S. E., & Weir, G. C. (2014). The pathophysiology of type 2 diabetes mellitus and its treatment. New England Journal of Medicine, 374(5), 516-526.

O'Neill, A., & O'Neill, P. (2021). Effectiveness of lifestyle interventions in type 2 diabetes and obesity: A review. Diabetes and Metabolism Research and Reviews, 37(5), e3412.

Perry, C. L., & Marshall, E. (2021). The impact of non-pharmacological therapies on quality of life in diabetes and obesity. Journal of Lifestyle Medicine, 4(2), 45-52.

Rosen, E. D., & Spiegelman, B. M. (2022). Obesity and diabetes: Mechanisms of metabolic disease. Cell, 171(4), 695-708.

Thomas, D. M., & Kern, M. (2020). Role of physical activity in the management of obesity and diabetes. Sports Medicine, 50(10), 1563-1573.

World Health Organization (WHO). (2023). Global health estimates 2023: Mortality and burden of disease. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/diabetes

Yuan, Z., & Zhai, C. (2022). Non-pharmacological approaches to managing type 2 diabetes and obesity. Diabetes Therapy, 13(4), 763-773.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Bárbara Aparecida Barcelos Carvalho, Maria Clara Trettel de Oliveira, Lucas Vilela Camilo, João Vitor Guareschi, Bruno Rafaell Machado Oliveira, Valentina Mossini Gratão, Luís Fernando Trindade dos Santos, Pedro Lucas Oliveira Rassi, Beatriz Neves de Souza, Jonathan Dalton Doering, Carlos Antônio Carvalhaes Filho

Downloads

Download data is not yet available.
1 1